{"document_type": "article", "byline": {"person": [{"role": "reported", "firstname": "Katie", "organization": "", "rank": 1, "lastname": "THOMAS"}], "original": "By KATIE THOMAS"}, "news_desk": "Business", "slideshow_credits": null, "abstract": null, "multimedia": [{"type": "image", "url": "images/2016/12/09/business/10TRUMPDRUG1/10TRUMPDRUG1-thumbWide.jpg", "legacy": {"wide": "images/2016/12/09/business/10TRUMPDRUG1/10TRUMPDRUG1-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "width": 190, "subtype": "wide", "height": 126}, {"type": "image", "url": "images/2016/12/09/business/10TRUMPDRUG1/10TRUMPDRUG1-articleLarge.jpg", "legacy": {"xlarge": "images/2016/12/09/business/10TRUMPDRUG1/10TRUMPDRUG1-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "412"}, "width": 600, "subtype": "xlarge", "height": 412}, {"type": "image", "url": "images/2016/12/09/business/10TRUMPDRUG1/10TRUMPDRUG1-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/12/09/business/10TRUMPDRUG1/10TRUMPDRUG1-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "width": 75, "subtype": "thumbnail", "height": 75}], "headline": {"print_headline": "Wary Drug Makers Move  to Avert Future Attacks", "main": "Wary Drug Makers Move to Fend Off Further Attacks Under Donald Trump"}, "print_page": "16", "keywords": [{"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Prices (Fares, Fees and Rates)", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "United States Politics and Government", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Trump, Donald J", "is_major": "N", "rank": "4", "name": "persons"}, {"value": "Health Insurance and Managed Care", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Biotechnology and Bioengineering", "is_major": "N", "rank": "6", "name": "subject"}], "snippet": "Even before the president-elect vowed \u201cto bring down drug prices,\u201d many companies began taking a pre-emptive approach on pricing....", "source": "The New York Times", "lead_paragraph": "Even before the president-elect vowed \u201cto bring down drug prices,\u201d many companies began taking a pre-emptive approach on pricing.", "word_count": "1109", "pub_date": "2016-12-09T22:38:58+0000", "subsection_name": null, "blog": [], "type_of_material": "News", "section_name": "Business Day", "web_url": "http://www.nytimes.com/2016/12/09/business/donald-trump-drug-prices-pharma-stocks.html", "_id": "584b328995d0e03926075318"}